TRAW•benzinga•
Traws Pharma Publishes Key Clinical Efficacy Data For Rigosertib, Oncology Asset For Which Development And Commercialization Partners Are Being Actively Sought, In Patients With RDEB SCC
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 3, 2025 by benzinga